Global health service company Cigna today announced it is expanding access to its popular Coach by Cigna health and fitness mobile application to make it more broadly available to its clients and customers. Coach is now available on both Apple® iOS and Android™ mobile smart devices.
Currently a go-to health and fitness app for more than 350,000 users in 15 nations in nine languages, Coach by Cigna is now available at no charge in the App Store ℠ and Google Play™ stores for mobile devices that have either the Apple® iOS9 or the Android™ Lollipop operating system.
To view the multimedia release go to:
http://www.multivu.com/players/English/7448831-coach-by-cigna-fitness-app/
The Investor Desk Presents US Highland, Inc. (OTC PINK: UHLN), a diversified product development, sales, and marketing company.
Since its founding in 1997 as Highland AB in Sweden, the Texas-based company has been developing and manufacturing high-performance single cylinder and V-twin powertrains used for a variety of applications. In September 2015, the publicly traded company began diversifying its operations, guiding startups in the marketing, reselling, and distributing of their products, as well as helping customers establish their brand and penetrate the U.S. market.
Overseeing the company’s growth is chief executive officer and president Josh Whitaker, a marketing executive with global experience in technology marketing, strategy, and implementation. Whitaker has worked with high-profile brands like Red Bull and Under Armour, as well as industry leading companies like Tucker Rocky Distributing and KTM Motorcycles.
Over the past two decades, US Highland, Inc. has tapped a variety of distribution channels, enabling growing businesses, both domestic and foreign, to launch their products in the United States whether wholesale, retail, or over the Internet.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7660851-us-highland-the-investor-desks-new-company/
The Amgen Foundation announced today that it will invest more than $4 million to support and strengthen the Amgen Biotech Experience program across the United States, Puerto Rico, United Kingdom and Ireland. The Amgen Biotech Experience includes an engaging series of labs that effectively bring biotechnology into classrooms. This new commitment will also strengthen the program’s alignment with the United States’ Next Generation Science Standards, which are focused on engaging students in more authentic science learning experiences. With the support of Education Development Center, Inc. (EDC), the global nonprofit leading the Amgen Biotech Experience Program Office, the investment is expected to empower 1,000 teachers who will reach more than 150,000 new students with the labs over the next two years.
“We are very excited to extend our commitment to the Amgen Biotech Experience, a program that began 25 years ago, with the intent to ignite a deep passion for innovation and scientific discovery in students,” said Robert A. Bradway, chairman and chief executive officer of Amgen. “This program, which provides advanced biotech curriculum and professional-grade lab equipment at no cost to schools, has opened countless students’ eyes to the world of biotechnology, fueling potential long term advancements to both medicine and society.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7414055-amgen-biotech-experience-grant/
If there’s one thing that socially responsible businesses have learned, it’s that they can’t go at it alone. Whether it’s implementing responsible sourcing initiatives or creating a positive corporate model to make an impact on sustainability, there is strength in numbers. So where did Ben & Jerry’s turn for help and inspiration for its latest ice cream flavor? Colorado-based New Belgium Brewing. Never has the phrase “polishing off a pint” been so perfectly poised in any partnership for a delicious double-entendre.
Collectively committed to making a better impact in their global communities, the two B Corp companies proudly introduced Salted Caramel Brown-ie Ale ice cream, which will be featured in Ben & Jerry’s Scoop Shops as well as in pints across the country as a Limited Batch flavor this fall (MSRP $4.89). The concoction consists of New Belgium Brown Ale Ice Cream with Salted Caramel Swirls and Fudge Brownies. The ice cream, arriving on shelves this month, was unveiled Wednesday evening at a Washington D.C. launch “Brew-Ha-Ha” in the confines of the historic Howard Theatre. The launch event was heralded as “a night of music, climate activism, beer, and ice cream.” Musicians Galactic and Dr. Dog performed at the unveiling of Ben & Jerry’s newest ice cream flavor to highlight climate activism.
To view the multimedia release go to:
http://www.multivu.com/players/English/7648451-ben-and-jerry-s-new-belgium-brewery/
Blood is an essential component for life, but many people do not think about it until the need is critical. Each year 234 million major operations are performed worldwide, many involving blood transfusions or treatments resulting in a continuous need for donations.
That’s why Abbott (NYSE: ABT) and Real Madrid soccer star Cristiano Ronaldo are partnering to bring even more attention to this important cause. Regarded as one of the top soccer players in the world, Ronaldo will serve as the first global ambassador for the BE THE 1™ movement – developed to inspire young people around the world to regularly donate blood.
“We can all make a difference by donating blood. Each donation can benefit up to three people in emergency situations and for long-term medical treatments,” said Cristiano Ronaldo, forward for Real Madrid and Captain for Portugal National Football. “That’s why I am enthusiastic to be partnering with Abbott to bring awareness to the importance of blood donation and to encourage people around the world to become lifelong blood donors and help save lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7668251-abbott-cristiano-ronaldo-donate-blood/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
The 1-year Full-Time MBA is the School’s flagship program with just about 100 MBA students. It is a challenging life time experience to learn the art of management and grow personally and professionally.
Full-Time MBA structure is organized around three cornerstones: Planning and Innovating, Controlling and Investing, Leading People and Processes. These core courses represent the competence requirements of a global manager.
To view the Multimedia News Release, go to http://www.multivu.com/players/uk/7674251-sda-bocconi-1-year-full-time-mba/
The Obama administration is holding the White House Summit on Nuclear Energy today discussing the role of nuclear energy in reducing carbon emissions linked to the threat of climate change. The event will be live streamed on WhiteHouse.gov and YouTube beginning at 1 p.m. ET.
“Nuclear energy has a really important role to play in the fight against climate change, and I think administrations in the past have recognized this but they’ve tended to be kind of quiet about it,” said Eileen Claussen, founder of the Pew Center on Global Climate Change.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7677651-nei-nuclear-energy-summit/
Global internet sensation Joseph Griffin made his triumphant return to Las Vegas on Thursday, Nov. 19, to properly capture the sights and sounds of the iconic Las Vegas Strip. This time, he filmed a few familiar places from his original ‘selfie’ video paired with additional only in Vegas experiences.
Griffin garnered the attention of more than 7 million YouTube views with his GoPro goof – as he documented his very first trip to Las Vegas with the camera pointed directly at his face in selfie mode. This time, Las Vegas created a double-sided GoPro for Griffin to capture the imagery while simultaneously providing his colorful commentary.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7266355-lvcva-las-vegas-redo/
Volvo Cars, the premium car maker, will work together with Microsoft, the leading platform and productivity company, to jointly develop next generation automotive technologies.
The two companies today revealed how Microsoft HoloLens, the world’s first fully untethered holographic computer, might be used in future to redefine how customers first encounter and explore a car, as well as how cars might be bought and sold in future.
Areas of future collaboration between the two companies could include autonomous driving technologies and the utilisation of data generated from connected cars to create new services.
Today’s HoloLens demonstration was conducted at Microsoft’s global headquarters in Redmond, USA, and showed how mixed reality might be used by customers to configure cars in three dimensions. With HoloLens, a powerful, wearable computer, holograms are mixed into the physical world.
To view the multimedia release go to:
http://www.multivu.com/players/English/7668751-volvo-the-virtual-showroom/
